RESUMEN
Chagas disease is a potentially life-threatening and neglected tropical disease caused by Trypanosoma cruzi. One of the most important challenges related to Chagas disease is the search for new, safe, effective, and affordable drugs since the current therapeutic arsenal is inadequate and insufficient. Here, we report a simple and cost-effective synthesis and the biological evaluation of the second generation of Mannich base-type derivatives. Compounds 7, 9, and 10 showed improved in vitro efficiency and lower toxicity than benznidazole, in addition to no genotoxicity; thus, they were applied in in vivo assays to assess their activity in both acute and chronic phases of the disease. Compound 10 presented a similar profile to benznidazole from the parasitological perspective but also yielded encouraging data, as no toxicity was observed. Moreover, compound 9 showed lower parasitaemia and higher curative rates than benznidazole, also with lower toxicity in both acute and chronic phases. Therefore, further studies should be considered to optimize compound 9 to promote its further preclinical evaluation.
Asunto(s)
Bases de Mannich/química , Bases de Mannich/farmacología , Tripanocidas/química , Tripanocidas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Animales , Chlorocebus aethiops , Replicación del ADN/efectos de los fármacos , Femenino , Concentración 50 Inhibidora , Bases de Mannich/metabolismo , Bases de Mannich/toxicidad , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Ratones , Simulación del Acoplamiento Molecular , Pruebas de Sensibilidad Parasitaria , Conformación Proteica , Relación Estructura-Actividad , Superóxido Dismutasa/antagonistas & inhibidores , Superóxido Dismutasa/química , Superóxido Dismutasa/metabolismo , Tripanocidas/metabolismo , Tripanocidas/toxicidad , Trypanosoma cruzi/enzimología , Trypanosoma cruzi/genética , Células VeroRESUMEN
Chalcones and Mannich bases are a group of compounds known for their cytotoxicities. In this study restricted chalcone analogue, compound 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one MT1, was used as a starting compound to synthesize new mono Mannich bases since Mannich bases may induce more cytotoxicity than chalcone analogue that they are derived from by producing additional alkylating center for cellular thiols. In this study, cyclic and acyclic amines were used to synthesize Mannich bases. All compounds were tested against Ca9-22 (gingival carcinoma), HSC-2, HSC-3 and HSC-4 (oral squamous cell carcinoma) as tumour cell lines and HGF (gingival fibroblasts), HPC (pulp cells) and HPLF (periodontal ligament fibroblasts) human normal oral cells as non tumour cell lines. Cytotoxicity, selectivity index (SI) values and potency selectivity expression (PSE) values expressed as a percentage were determined for the compounds. According to data obtained, the compound MT8 with the highest PSE value bearing N-methylpiperazine moiety seems to be a good candidate to develop new cytotoxic compounds and is suited for further investigation.
Asunto(s)
Indenos/síntesis química , Indenos/toxicidad , Bases de Mannich/síntesis química , Bases de Mannich/toxicidad , Antineoplásicos/síntesis química , Antineoplásicos/química , Antineoplásicos/toxicidad , Línea Celular , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Humanos , Hidroxibenzoatos/síntesis química , Hidroxibenzoatos/química , Hidroxibenzoatos/toxicidad , Indenos/química , Bases de Mannich/química , Estructura Molecular , Neoplasias/tratamiento farmacológicoRESUMEN
Phenoxodiol, an analogue of the isoflavone natural product daidzein, is a potent anti-cancer agent that has been investigated for the treatment of hormone dependent cancers. This molecular scaffold was reacted with different primary amines and secondary amines under different Mannich conditions to yield either benzoxazine or aminomethyl substituted analogues. These processes enabled the generation of a diverse range of analogues that were required for structure-activity relationship (SAR) studies. The resulting Mannich bases exhibited prominent anti-proliferative effects against SHEP neuroblastoma and MDA-MB-231 breast adenocarcinoma cell lines. Further cytotoxicity studies against MRC-5 normal lung fibroblast cells showed that the isoflavene analogues were selective towards cancer cells.
Asunto(s)
Isoflavonas , Bases de Mannich/síntesis química , Bases de Mannich/farmacología , Antineoplásicos/síntesis química , Antineoplásicos/química , Antineoplásicos/farmacología , Antineoplásicos/toxicidad , Neoplasias de la Mama/tratamiento farmacológico , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Humanos , Concentración 50 Inhibidora , Isoflavonas/síntesis química , Isoflavonas/química , Isoflavonas/toxicidad , Bases de Mannich/química , Bases de Mannich/toxicidad , Estructura Molecular , Relación Estructura-ActividadRESUMEN
Synthesis, physicochemical and anticonvulsant properties of new N-Mannich bases 3-24 derived from 5-cyclopropyl-5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-hydantoins were described here. Initial anticonvulsant screening was performed using intraperitoneal (i.p.) maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizures tests. Selected derivatives were also screened in the 6-Hz test. The neurotoxicity was determined applying the rotorod test. The pharmacological results revealed that the majority of compounds were effective in MES and/or scPTZ tests. The quantitative studies after oral administration into rats showed that several molecules were more potent than phenytoin and ethosuximide which were used as reference antiepileptic drugs. From the whole series the most active was 3-[(4-phenylpiperazin-1-yl)-methyl]-5-cyclopropyl-5-phenyl-imidazolidine-2,4-dione (3) with the ED(50) value of 5.29 mg/kg in the MES test.
Asunto(s)
Anticonvulsivantes/síntesis química , Hidantoínas/química , Bases de Mannich/síntesis química , Administración Oral , Animales , Anticonvulsivantes/química , Anticonvulsivantes/uso terapéutico , Anticonvulsivantes/toxicidad , Modelos Animales de Enfermedad , Masculino , Bases de Mannich/química , Bases de Mannich/uso terapéutico , Bases de Mannich/toxicidad , Ratones , Estructura Molecular , Síndromes de Neurotoxicidad/etiología , Ratas , Ratas Sprague-Dawley , Convulsiones/tratamiento farmacológico , Relación Estructura-ActividadRESUMEN
A novel series of coumarinyl Mannich bases (3a-1) have been synthesized by reacting 3-acetyl coumarin (1) with various substituted secondary amines (2a-1) in presence of paraformaldehyde. The structures of the newly synthesized compounds were characterized by IR, 1H NMR, 13C NMR and HRMS (high resolution mass spectral) data. Title compounds were screened for in vivo acute anti-inflammatory activity using the carrageenan-induced rat paw edema assay model. Among the compounds tested, 3-[3-(diethylamino)propanoyl]-2H-chromen-2-one (3a)and 3-[3-(piperidine-1-yl) propanoyl]-2H-chromen-2-one (3c) showed 63.1 and 66.7% inhibition, respectively, as compared to the standard drug diclofenac (CAS 15307-86-5, 68.8%). These potent compounds showed encouraging analgesic andantipyretic activities.
Asunto(s)
Analgésicos no Narcóticos/síntesis química , Analgésicos no Narcóticos/farmacología , Antiinflamatorios/síntesis química , Antiinflamatorios/farmacología , Cumarinas/síntesis química , Cumarinas/farmacología , Bases de Mannich/síntesis química , Bases de Mannich/farmacología , Ácido Acético , Analgésicos no Narcóticos/toxicidad , Animales , Antiinflamatorios/toxicidad , Cumarinas/toxicidad , Evaluación Preclínica de Medicamentos , Femenino , Fiebre/inducido químicamente , Fiebre/tratamiento farmacológico , Indicadores y Reactivos , Espectroscopía de Resonancia Magnética , Masculino , Bases de Mannich/toxicidad , Espectrometría de Masas , Ratones , Dimensión del Dolor/efectos de los fármacos , Solventes , Espectrofotometría Infrarroja , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de Fourier , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/patologíaRESUMEN
A series of 12 new Mannich bases with chalcone core structure were synthesized as potential antineoplastic agents, via N-aminomethylation of two parent 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones. The newly synthesized compounds as well as the chalcone prototypes were evaluated for cytotoxicity in the human pre-B-cell leukemia cell line BV-173 using the MTT-dye reduction assay. The tested compounds exhibited concentration-dependent cytotoxic effects at low micromolar concentrations. Ten of the Mannich bases characterized by significant activity in BV-173 were further evaluated against the chronic myeloid leukemia cell line K-562 and were found to suppress the growth of these cells at relatively higher concentrations as compared to the former tumor model. Selected Mannich bases induced programmed cell death in BV-173 at a concentration of 2.5muM as evidenced by the encountered DNA-laddering. Taken together our data suggest that the presented heterocyclic chalcone derived Mannich bases necessitate detailed pharmacological evaluation in order to define further the structure activity relationships, in a larger spectrum of tumor models and to elucidate the mechanisms implicated in the observed cytotoxic effects.
Asunto(s)
Benzoxazoles/síntesis química , Benzoxazoles/toxicidad , Citotoxinas/química , Citotoxinas/toxicidad , Bases de Mannich/química , Bases de Mannich/toxicidad , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Benzoxazoles/química , Línea Celular Tumoral , Chalcona/análogos & derivados , Citotoxinas/síntesis química , Fragmentación del ADN/efectos de los fármacos , Ratones , Leucemia-Linfoma Linfoblástico de Células Precursoras BRESUMEN
The paper describes synthesis and antibacterial study of biologically active Mannich bases of carboxamide derivative employing Mannich reaction of 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a pentahydroxy naphthacene carboxamide with various sulfonamides/secondary amines . They were analysed by elemental analysis and characterized by UV, IR and (1)H NMR spectroscopic studies. The Mannich bases were screened for antibacterial activity against various gram-negative bacteria at various concentrations and were analysed statistically. The result has shown that the compounds are quite active against pathogens under study and were non-toxic. All the synthesized compounds were found to be low lethal as ascertained by LD50 test.
Asunto(s)
Antibacterianos/síntesis química , Antibacterianos/farmacología , Bases de Mannich/síntesis química , Naftacenos/síntesis química , Animales , Antibacterianos/toxicidad , Indicadores y Reactivos , Dosificación Letal Mediana , Espectroscopía de Resonancia Magnética , Bases de Mannich/toxicidad , Ratones , Naftacenos/farmacología , Pasteurella multocida/efectos de los fármacos , Salmonella enteritidis/efectos de los fármacos , Espectrofotometría Infrarroja , Espectrofotometría UltravioletaRESUMEN
A series of new 4-arylpiperazine derivatives of isothiazolopyridine of Mannich base type and their non-4-arylpiperazine analogues (3 and 4) were synthesized and assayed as potential analgesic agents. Pharmacological assay demonstrated that all the compounds prepared, without exception, displayed significant activity in the mouse writhing assay. The analgesic action, expressed as ED50, was found to be 2-10 times more potent than that of acetylsalicylic acid and 1.5-10 times weaker than that of morphine, these being used as standards. The toxicities (LD50) of the investigated derivatives varied and ranged from 250 to 2000 mg/kg. Additionally, the computational investigations were performed in order to find correlation between molecular structure and biological effects (toxicity, analgesic action) of discussed compounds. Useful model was found for toxicity assessment.
Asunto(s)
Analgésicos/síntesis química , Bases de Mannich/síntesis química , Piperazinas/síntesis química , Piridinas/síntesis química , Tiazoles/síntesis química , Analgésicos/farmacología , Analgésicos/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Benzoquinonas , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Calor , Dosificación Letal Mediana , Masculino , Bases de Mannich/farmacología , Bases de Mannich/toxicidad , Ratones , Modelos Químicos , Estructura Molecular , Umbral del Dolor/efectos de los fármacos , Piperazinas/farmacología , Piperazinas/toxicidad , Piridinas/farmacología , Piridinas/toxicidad , Relación Estructura-Actividad , Tiazoles/farmacología , Tiazoles/toxicidadRESUMEN
A series of 2-[[4-(substituted-phenyl/ benzyl)-1-piperazinyllmethyl]-6-(4-methoxyphenyl)-3(2H)pyridazinone derivatives was prepared and examined for analgesic and anti-inflammatory activities. The structures of these new pyridazinone derivatives were confirmed by their IR and 1H-NMR spectra and elementary analysis. Among the compounds prepared, 2-[[4-(4-fluorophenyl)-1-piperazinyl]methyl]-6-(4-methoxyphenyl)-3(2H)pyridazinone IVe was found to be a most promising analgesic and anti-inflammatory agent. Compound IVe showed more potent analgesic activity than acetylsalicyclic acid in the phenylbenzoquinone-induced writhing test. Also IVe showed anti-inflammatory activity comparable to that of the standard compound indometacin against the carrageenan-induced paw edema. Side effects of the compounds were examined on gastric mucosa. None of the compounds showed a gastric ulcerogenic effect compared with reference nonsteroidal anti-inflammatory drugs. On the basis of the available data, the structure-activity relationship of the series of 2-[[4-(substituted-phenyl/benzyl)-1-piperazinyl]methyl]-6-(4-methoxyphenyl)-3(2H) pyridazinones is also discussed.
Asunto(s)
Analgésicos/síntesis química , Analgésicos/farmacología , Antiinflamatorios no Esteroideos/síntesis química , Antiinflamatorios no Esteroideos/farmacología , Bases de Mannich/síntesis química , Bases de Mannich/farmacología , Piridazinas/síntesis química , Piridazinas/farmacología , Animales , Benzoquinonas , Edema/inducido químicamente , Edema/patología , Edema/prevención & control , Pie/patología , Indicadores y Reactivos , Espectroscopía de Resonancia Magnética , Masculino , Bases de Mannich/toxicidad , Ratones , Contracción Muscular/efectos de los fármacos , Piridazinas/toxicidad , Solventes , Espectrofotometría Infrarroja , Úlcera Gástrica/inducido químicamente , Relación Estructura-ActividadRESUMEN
Mono-Mannich bases, 3-amino-1-aryl-1-propanone hydrochlorides (Ig1-Ig4), and their corresponding azine derivatives, N,N'-bis(3- amino-1-aryl-propylidene) hydrazine dihydrochlorides (D1-D4), were synthesized and their anticonvulsant activities were evaluated. Alterations in biological activity depending on modifications in chemical structure were also followed. The aryl part was phenyl in Ig1, D1, Ig2, D2, Ig3, D3, or p-hydroxyphenyl in Ig4, and D4. The amine part was dimethylamine in Ig1, D1, Ig4, and D4, piperidine in Ig2, D2 or morpholine in Ig3, D3. Compounds D2, D3, and D4 are new. The anticonvulsant activity was determined by maximal electroshock (MES) and subcutaneous metrazole (pentetrazol; scMet) tests. The rotorod toxicity test was used for determining neurological deficits. While the compounds were not effective in scMet, they were found to exert protective effect in MES. The results of MES are as follows: Compound [dose level (mg/kg), time (h)]: Ig1 [30 (0.5 h), 100 (0.5 h)]; Ig2 [30 (0.5 h, 4 h)]; Ig3 [30 (0.5 h), 100 (0.5 h), 300 (0.5 h, 4 h)]; Ig4 [300 (0.5 h, 4 h), 100 (4 h)]; D1 [30 (0.5 h)]; D3 [100 (0.5 h,4 h), 300 (0.5 h), 30 (4 h)]]; D4 [300 (0.5 h, 4 h)]. D2 did not show any anticonvulsant activity in both tests. Ig1, Ig2, D1, D2, and D3 exhibited neurotoxicity. Compounds Ig2, D1, and D2 were neurotoxic at 100 mg/kg dose level at 0.5 h. Ig1 was neurotoxic at 300 mg at 0.5 h, D3 was neurotoxic at 300 mg at 4 h. Conversion of mono-Mannich bases to their corresponding azine derivatives generally decreased the anticonvulsant activity. Ig3, Ig4 and D4 seem to be promising candidates to develop new anticonvulsant compounds for grand mal epilepsy for further synthesis and in vivo studies, since they were effective in MES screening and no neurotoxicity was observed with them.
Asunto(s)
Anticonvulsivantes/síntesis química , Anticonvulsivantes/farmacología , Compuestos Aza/síntesis química , Compuestos Aza/farmacología , Bases de Mannich/síntesis química , Bases de Mannich/farmacología , Quinolinas/síntesis química , Quinolinas/farmacología , Animales , Anticonvulsivantes/toxicidad , Compuestos Aza/toxicidad , Convulsivantes , Electrochoque , Indicadores y Reactivos , Bases de Mannich/toxicidad , Pentilenotetrazol , Equilibrio Postural/efectos de los fármacos , Ratas , Convulsiones/inducido químicamente , Convulsiones/prevención & controlRESUMEN
Thioredoxin reductase (TrxR) is the homodimeric flavoenzyme that catalyzes reduction of thioredoxin disulfide (Trx). For Plasmodium falciparum, a causative agent of tropical malaria, TrxR is an essential protein which has been validated as a drug target. The high-throughput screening of 350000 compounds has identified Mannich bases as a new class of TrxR mechanism-based inhibitors. During catalysis, TrxR conducts reducing equivalents from the NADPH-reduced flavin to Trx via the two redox-active cysteine pairs, Cys88-Cys93 and Cys535'-Cys540', referred to as N-terminal and C-terminal cysteine pairs. The structures of unsaturated Mannich bases suggested that they could act as bisalkylating agents leading to a macrocycle that involves both C-terminal cysteines of TrxR. To confirm this hypothesis, different Mannich bases possessing one or two electrophilic centers were synthesized and first studied in detail using glutathione as a model thiol. Michael addition of glutathione to the double bond of an unsaturated Mannich base (3a) occurs readily at physiological pH. Elimination of the amino group, promoted by base-catalyzed enolization of the ketone, is followed by addition of a second nucleophile. The intermediate formed in this reaction is an alpha,beta-unsaturated ketone that can react rapidly with a second thiol. When studying TrxR as a target of Mannich bases, we took advantage of the fact that the charge-transfer complex formed between the thiolate of Cys88 and the flavin in the reduced enzyme can be observed spectroscopically. The data show that it is the C-terminal Cys 535'-Cys540' pair rather than the N-terminal Cys88-Cys93 pair that is modified by the inhibitor. Although alkylated TrxR is unable to turn over its natural substrate Trx, it can reduce low M(r) electron acceptors such as methyl methanethiolsulfonate by using its unmodified N-terminal thiols. On the basis of results with chemically distinct Mannich bases, a detailed mechanism for the inactivation of TrxR is proposed.
Asunto(s)
Inhibidores Enzimáticos/química , Bases de Mannich/química , Bases de Mannich/toxicidad , Metilmetanosulfonato/análogos & derivados , Plasmodium falciparum/enzimología , Reductasa de Tiorredoxina-Disulfuro/antagonistas & inhibidores , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Alquilantes/química , Animales , Ácido Ditionitrobenzoico/química , Relación Dosis-Respuesta a Droga , Glutatión/química , Glutatión Reductasa/antagonistas & inhibidores , Glutatión Reductasa/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Cinética , Bases de Mannich/síntesis química , Metilmetanosulfonato/química , Modelos Químicos , NADP/química , Oxidación-Reducción , Plasmodium falciparum/efectos de los fármacos , Propiofenonas/químicaRESUMEN
2-Dimethylaminomethyl-1-phenyl-2-propen-1-one hydrochloride (3) is a novel cytotoxic and anticancer agent. The objective of this study was to obtain information pertaining to possible toxic symptoms detected by in vivo evaluations in mice and an in vitro test for mutagenicity. The data obtained revealed that 3 had no effect on alanine transaminase, aspartate transaminase, HDL cholesterol and protein concentrations in sera nor were variations in the numbers of red and white blood cells detected. Furthermore autopsies of treated mice revealed no pathological symptoms in the heart, kidney, brain, spleen and testes. However elevation of the concentrations of total cholesterol, triglycerides, creatinine and urea were noted in treated mice as well as inflammation of the liver and lungs. Chromosomal aberrations were detected in a micronuclei test. In the Ames test, compound 3 was converted into one or more mutagens in the presence (but not the absence) of a murine liver homogenate. Thus future molecular modifications of 3 should bear in mind approaches to reduce or minimize unwanted side effects.
Asunto(s)
Antineoplásicos/toxicidad , Propiofenonas/toxicidad , Animales , Recuento de Células Sanguíneas , Células de la Médula Ósea/efectos de los fármacos , Colesterol/sangre , Creatinina/sangre , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Inyecciones Intraperitoneales , Pruebas de Función Hepática , Bases de Mannich/química , Bases de Mannich/toxicidad , Ratones , Pruebas de Micronúcleos , Pruebas de Mutagenicidad , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Triglicéridos/sangre , Urea/sangreRESUMEN
Some acetophenone-derived bis Mannich bases were synthesized: bis[beta-benzoylethyl]ethylamine hydrochloride (IIa), bis[beta-(p-methylbenzoyl)ethyl]ethylamine hydrochloride (IIb), bis[beta-(p-chlorobenzoyl)ethyl]ethy- lamine hydrochloride (IId), bis[(2-thienylcarbonyl)ethyl]ethylamine hydrochloride (IIe); some corresponding piperidinol derivatives: 3-benzoyl-1-ethyl-4-phenyl-4-piperidinol hydrochloride (IIIa), 1-ethyl-3-(p-methyl- benzoyl)-4-(p-methylphenyl)-4-piperidinol hydrochloride (IIIb), 1-ethyl-3-(p-methoxybenzoyl)-4-(p-methoxy- phenyl)-4-piperidinol hydrochloride (IIIc), 1-ethyl-3-(p-chlorobenzoyl)-4-(p-chlorophenyl)-4-piperidinol hydrochloride (IIId), 1-ethyl-4-(2-thienyl)-3-(2-thienylcarbonyl)-4-piperidinol hydrochloride (IIIe); and some representative quaternary piperidinols: 3-benzoyl-1-ethyl-4-hydroxy-1-methyl-4-phenylpiperidinium iodide (IIIf), 1-ethyl-4-hydroxy-1-methyl-3-(p-methylbenzoyl)-4-(p-methylphenyl)piperidinium iodide (IIIg). Toxicity was tested by the brine shrimp bioassay as an intermediate test before further in vivo animal experiments. Piperidine derivatives were found to be more potent than bis Mannich bases. Quaternary piperidine derivatives IIIf and IIIg and also non-quaternary piperidine derivatives IIIb, IIIe, IIIc and IIId were more toxic than 5-fluorouracil in brine shrimp bioassay. Except for IIe, bis Mannich bases were not effective. Quaternization and conversion of bis Mannich bases to corresponding piperidines improved the toxicity. The lipid solubility of the compounds may not affect the toxicity. From these findings the quaternary piperidine derivatives IIIf and IIIg could be used in further drug development and also for in vivo experiments.
Asunto(s)
Acetofenonas/química , Artemia , Bases de Mannich/toxicidad , Piperidinas/toxicidad , Alternativas a las Pruebas en Animales , Animales , Bioensayo , Relación Dosis-Respuesta a Droga , Longevidad/efectos de los fármacos , Bases de Mannich/química , Peso Molecular , Octanoles/química , Piperidinas/química , Solubilidad , Agua/químicaRESUMEN
Jurkat cells were exposed to representative acetophenone-derived mono Mannich bases 2 and 3 and also cyclic Mannich base C1 in culture conditions to see the alterations in the most abundant cellular thiol, glutathione and also some of the enzymes in its metabolic pathway. Jurkat cells were exposed to the compounds for 24 h in cell culture medium with fetal bovine serum (1%) at 37 degrees C under a humidified atmosphere of 95% air and 5% CO2. Mannich bases generally increased total glutathione level (123-151% of control). Glutathione S-transferase (GST) activity also increased (150-363% of control), while glutathione disulfide reductase (GRD) activity was not affected. The increase in cellular glutathione level may possibly result from de novo glutathione synthesis. The consumption of the glutathione due to alkylation by Mannich bases might have stimulated the enzymes in the gamma-glutamyl cycle in our experimental design, where the cells had nutrients and time to react with their feedback mechanisms. A remarkable increase in GST activity might be a compensatory up-regulation to detoxify Mannich bases by conjugating them with cellular thiols.
Asunto(s)
Glutatión Transferasa/metabolismo , Glutatión/metabolismo , Células Jurkat/efectos de los fármacos , Células Jurkat/enzimología , Bases de Mannich/toxicidad , NADH NADPH Oxidorreductasas/metabolismo , Acetofenonas/química , Relación Dosis-Respuesta a Droga , Glutatión Reductasa , Humanos , Células Jurkat/citología , Bases de Mannich/química , Reductasa de Tiorredoxina-DisulfuroRESUMEN
Some acetophenone derived bis Mannich bases (B1-B5) and piperidinols (C1, C4), which are the structural isomers of B1 and B4, and also quaternary piperidine derivative C6 were synthesized and studied for anticonvulsant activity. Of the compounds, C6 was reported for the first time. Chemical structures of the compounds were confirmed by UV, IR, 1H-NMR, 13C-NMR, mass spectra and elemental analysis. Their anticonvulsant activities were determined by maximal electroshock (MES), subcutaneous metrazol (scMet) tests and rotarod test for neurological deficits. According to the activity studies, B2, B4, C1 and C4 derivatives were found to be protective against MES at 30 mg/kg and above. B1, B2, B3, B4, C4 and C6 derivatives were found to be protective against scMet. at different dose levels ranging from 30 to 300 mg/kg. Since no neurotoxicity was detected for the compounds B4 and C4, they seem to be candidate compounds for further synthesis and in vivo studies for their potential anticonvulsant activity.
Asunto(s)
Anticonvulsivantes/síntesis química , Anticonvulsivantes/farmacología , Bases de Mannich/síntesis química , Bases de Mannich/farmacología , Piperidinas/síntesis química , Piperidinas/farmacología , Animales , Anticonvulsivantes/toxicidad , Convulsivantes/farmacología , Ciclización , Diseño de Fármacos , Electrochoque , Indicadores y Reactivos , Masculino , Bases de Mannich/toxicidad , Ratones , Síndromes de Neurotoxicidad/psicología , Pentilenotetrazol/antagonistas & inhibidores , Piperidinas/toxicidad , Equilibrio Postural/efectos de los fármacos , Espectrofotometría Ultravioleta , Relación Estructura-ActividadRESUMEN
Thirty 1-aryl-5-dimethylamino-1-penten-3-one hydrohalides and related compounds were prepared as candidate anticonvulsants and evaluated in maximal electroshock seizure (MES), subcutaneous pentylenetetrazole threshold, and neurotoxicity screens. Following administration by the intraperitoneal route, many of the compounds were active in the MES screen, whereas only 10% of the Mannich bases afforded protection in the subcutaneous pentylenetetrazole test. Quantitation of half of the compounds prepared revealed that many had activity comparable with that of clinically useful drugs in the MES screen. The anticonvulsant properties of eight of the compounds following oral administration were reduced considerably or abolished compared with those following intraperitoneal administration. Various synthetic strategies for future development of potential anticonvulsants are outlined.
Asunto(s)
Anticonvulsivantes/farmacología , Cetonas/farmacología , Bases de Mannich/farmacología , Animales , Anticonvulsivantes/química , Anticonvulsivantes/toxicidad , Fenómenos Químicos , Química Física , Cetonas/síntesis química , Cetonas/toxicidad , Bases de Mannich/química , Bases de Mannich/toxicidad , Ratones , Enfermedades del Sistema Nervioso/inducido químicamente , Relación Estructura-ActividadAsunto(s)
Anticonvulsivantes/síntesis química , Bases de Mannich/síntesis química , Propiofenonas/síntesis química , Animales , Anticonvulsivantes/farmacología , Anticonvulsivantes/toxicidad , Electrochoque , Bases de Mannich/farmacología , Bases de Mannich/toxicidad , Ratones , Enfermedades del Sistema Nervioso/inducido químicamente , Pentilenotetrazol/antagonistas & inhibidores , Propiofenonas/farmacología , Propiofenonas/toxicidadRESUMEN
A new bis-Mannich base (NC758) derived from a conjugated styryl ketone has demonstrated activities against human and animal tumors, both in vitro and as xenografts in athymic mice. The present study examined the toxicity of this candidate anticancer drug, when administered intraperitoneally by undertaking LD50, acute dose-response and time-response toxicity studies using CD-1 mice following OECD guidelines. An LD50 of 46.9 +/- 1.4 mg/kg (males) and 65.2 +/- 1.5 mg/kg (females) was calculated using the moving averages method. Signs of toxicity included diarrhea, piloerection, and coma. Gross pathologic findings consisted of an acute fibrinous peritonitis in animals surviving 24 hr or more before death. The acute dose-response study revealed anorexia in mice 24 hr after receiving 25 mg/kg NC758 or more, lasting up to 72 hr in the 50 mg/kg treated group. Neutrophils were significantly elevated in the 25 and 50 mg/kg groups in conjunction with the observed acute peritonitis. Treatment (p = 0.0001), sex (p = 0.0008), and treatment/sex interaction (p = 0.0001) effects were seen in the myeloid-erythroid ratio (MER) of bone marrow. Pathologic changes included thymic necrosis (in all treated mice) and intestinal villous atrophy (in mice treated with 25 and 50 mg/kg). In time-response studies, pathological changes disappeared after 14 days, except for the MER which remained abnormal in males. It was concluded that NC758 was corrosive; hence future studies should utilize the intravenous route, or be given intraperitoneally as divided doses.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Aminas/toxicidad , Antineoplásicos/toxicidad , Bases de Mannich/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Femenino , Dosificación Letal Mediana , Masculino , Ratones , Necrosis/inducido químicamente , Timo/efectos de los fármacos , Timo/patologíaRESUMEN
Mono- and di-Mannich bases derived from 4-(7'-bromo-1',5'-naphthyridin-4'-ylamino)phenol and 4-(7'-trifluoromethylquinolin-4'-ylamino)phenol were assayed for antimalarial activity (using an in vitro radioisotopic technique) against two isolates of Plasmodium falciparum. Many from these two series of compounds had an IC50 value (concentration of compound causing 50% inhibition of 3H-hypoxanthine incorporation) comparable to or better than those of mefloquine and amodiaquine, for both a chloroquine-sensitive isolate (FCQ-27) and the chloroquine-resistant isolate (K1). At least one compound, 2,6-bis (piperidin-1''-ylmethyl)-4-(7'-trifluoromethylquinolin -4'-ylamino)phenol (TN112), showed significant superior activity to the three antimalarials chloroquine, mefloquine and amodiaquine against both isolates. (Statistically superior activity compared to these three antimalarials was found for TN112, except that against the K1 isolate its activity was just outside the range of significance relative to mefloquine.) Some of the 7-bromo-1,5-naphthyridine Mannich bases were appreciably less toxic in mice than amodiaquine.
Asunto(s)
Aminas/farmacología , Aminas/farmacocinética , Antimaláricos/farmacología , Bases de Mannich/farmacología , Plasmodium falciparum/efectos de los fármacos , Animales , Antimaláricos/farmacocinética , Antimaláricos/toxicidad , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos , Dosificación Letal Mediana , Bases de Mannich/metabolismo , Bases de Mannich/farmacocinética , Bases de Mannich/toxicidad , Ratones , Naftiridinas/metabolismo , Fenoles/metabolismo , Plasmodium falciparum/metabolismoRESUMEN
Analogs of some antineoplastic and cytotoxic Mannich bases derived from conjugated styryl ketones were prepared and evaluated for activity in the P-388 lymphocytic leukemia screen. Most of the new compounds had lower antineoplastic and murine toxicity than the parent compounds. Antimicrobial evaluation of some oximes and alcohols related to the Mannich bases revealed activity against certain Gram-positive bacteria and fungi. Primary pharmacological evaluation showed that some compounds containing a dimethylaminomethyl group displayed analgesic and antihistaminic properties. Five of the Mannich bases were evaluated as respiratory inhibitors in mitochondria derived from hepatic tumors, liver tissue from tumor-bearing animals, and normal rat liver. No statistical difference between the sensitivity of the three tissues to the compounds was obtained.